Clinical Trial Update: The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

View source ↗

Summary

This clinical trial update reports an ongoing study evaluating a combination of recombinant human thrombopoietin (rHuTPO) and recombinant human interleukin-11 (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Thrombocytopenia

Drugs mentioned

• recombinant human interleukin-11 (rHuIL-11) (interleukin-11)
• recombinant human thrombopoietin (rHuTPO) (thrombopoietin)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Thrombocytopenia | Status: UNKNOWN